SEC Tracker
Get the app

Biomerica BMRA

Biomerica announces 2026 annual meeting

Proxy statement

Form
DEF 14A
Filed
Importance
Routine
  1. Scheduled for December 11, 2026
  2. Includes director elections and executive compensation approval
  3. Proxy materials available online

Written from the DEF 14A on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Biomerica files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2835 and related industry codes: the same peer list as the financial tables.

  1. Protagenic Therapeutics, Inc.\new PTIX public float $7M, Sep 30, 2025
  2. Adial Pharmaceuticals ADIL public float $6M, Jun 30, 2025
  3. AIM ImmunoTech AIM public float $6M, Jun 30, 2025
  4. Vyome Holdings HIND public float $6M, Jun 30, 2025
  5. PharmaCyte Biotech PMCB public float $6M, Oct 31, 2025